FPGEE for National Association of Boards of Pharmacy (NABP) Practice Exam 2026 - Free NABP Practice Questions and Study Guide

Cystic fibrosis is a genetic condition that often leads to pancreatic insufficiency due to thickened secretions that obstruct the pancreatic ducts. This results in a reduced ability of the pancreas to release digestive enzymes, which are crucial for the proper breakdown and absorption of nutrients in the intestines. When nutrient absorption is impaired, it often leads to malabsorption syndromes, one of the key consequences being diarrhea.

In cystic fibrosis, patients commonly produce bulky, greasy stools that are difficult to pass, a condition referred to as steatorrhea, which is indicative of fat malabsorption. This malabsorption can also lead to frequent diarrhea as undigested food moves rapidly through the gastrointestinal tract. Therefore, the presence of diarrhea is a direct complication of the pancreatic deficiency associated with cystic fibrosis.

Understanding the link between pancreatic function and gastrointestinal symptoms is crucial for managing cystic fibrosis, as addressing the malabsorption with enzyme replacement therapy can help mitigate these complications, promoting better weight gain and overall health in affected individuals.